Skip to main content
Equibles
ALNY $177.24 -23.73%
ALNY logo
ALNY · Alnylam Pharmaceuticals, Inc.
Track ALNY — free

Use ALNY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ALNY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$177.24 -55.16 (-23.73%) Earnings today Q2 2026 earnings call transcript
Nasdaq-100 member Russell 1000 member Rebalance outlook locked
Market Cap
$23.31B
Shares
133.94M
Volume · Oct 29 11.8M Avg daily vol (3M) 1.91M
All webcasts

Earnings call · FY2026 Q3

Alnylam Pharmaceuticals, Inc. (ALNY) Q3 2026 Earnings Call

Concluded Oct 29, 2026 Audio replay
Oct 29, 2026 1:00:09 0 turns
Period
FY2026 Q3
Runtime
1:00:09
Sources
4 artifacts
Revenue $1.46B +16.7% YoY
Diluted EPS $15.72 +634.6% YoY
Gross margin · derived Q4 75.2% -9.0 pp YoY
Net income $2.17B +640.5% YoY
Open full screen Slides 33 8-K 10-Q

Listen to the call

Audio replay

Play the complete captured earnings call.

1:00:09 Audio

Audio replay

A speaker-labelled transcript is not available for this event yet.

Full-screen source Call document

ALNY alerts

Alnylam Pharmaceuticals, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →